iAtoday
The 2024 edition of Express Scripts Canada’s Drug Trends Webinar took place on April 30. Frédéric Leblanc, our strategic leader in drug programs, joined other industry specialists as a panelist.
Our expert commented on the results presented by Express Scripts Canada and discussed elements to monitor in 2024, as they will impact our drug management strategies:
- Introduction of the drug Wegovy in Canada1
- Importance of continuing initiatives for the transition to biosimilars
- Implementation of national universal pharmacare in Canada
Our top 10 drugs
Each year, we present our ranking and analysis of the ten drugs that account for the highest total drug costs for all group insurance plans.
See the latest edition, published last April.
| When it comes to drug management, our vision is to support the sustainability of drug plans while preserving the physical and mental health of plan members through ongoing access to an excellent drug plan. |
1 Wegovy is a drug indicated as an adjunct to diet and increased physical activity for weight management.
Also in this issue
- Financial literacy | New tools for group plan members
- My Client Space | Multi-factor authentication
- Grand défi Pierre Lavoie | Our team gets the kids moving
- DB plans and other pooled assets | Customized, specialized solutions
- Asset management | Jarislowsky Fraser announces the retirement of Bernard Gauthier
- Quarterly Update | March 31, 2024, edition is now available
- Travel assistance | Carefree travel for your clients